Question 1

What is Ocrevus (ocrelizumab)?

Accepted Answer

Ocrevus (ocrelizumab) is a humanized anti‑CD20 monoclonal antibody employed as an immunosuppressive therapy for multiple sclerosis.

Question 2

How many companies research Ocrevus (ocrelizumab)?

Accepted Answer

Based on our data, 30 companies research Ocrevus (ocrelizumab). This number is updated daily as we discover new companies through job posting analysis.

Question 3

What types of companies research Ocrevus (ocrelizumab)?

Accepted Answer

Ocrevus (ocrelizumab) is relevant across multiple industries including Higher Education, Hospitals and Health Care, Biotechnology Research. Companies range from startups to enterprises with 10,000+ employees.

Question 4

How does TheirStack track companies related to Ocrevus (ocrelizumab)?

Accepted Answer

TheirStack analyzes millions of job postings daily from company career pages, job boards, and recruitment platforms. When a company mentions Ocrevus (ocrelizumab) in their job descriptions, requirements, or responsibilities, we identify them as related to Ocrevus (ocrelizumab) and add them to our database.

Question 5

How can I get the full list of companies that research Ocrevus (ocrelizumab)?

Accepted Answer

You can access the complete list of 30 companies on TheirStack. The data includes company name, industry, size, location, funding, and revenue. Available via our web app or API.

Question 6

How often is the company data updated?

Accepted Answer

Our database is refreshed daily. We continuously monitor job postings to detect new companies researching Ocrevus (ocrelizumab) and update existing records.

Company	Country	Industry	Employees	Revenue	Technologies
Baylor College of Medicine	United States	Higher Education	14k	$2.3B	Ocrevus (ocrelizumab)
Kane Hall Barry Neurology	United States	Hospitals and Health Care	51	$2M	Ocrevus (ocrelizumab)
Roche	Switzerland	Biotechnology Research	107k	$68B	Ocrevus (ocrelizumab)
Mind	Australia	Hospitals and Health Care	730		Ocrevus (ocrelizumab)
CarepathRx	United States	Hospitals and Health Care	1k		Ocrevus (ocrelizumab)
NHS	United Kingdom	Hospitals and Health Care	193k	$105B	Ocrevus (ocrelizumab)
CENTRE HOSPITALIER DE CHATEAUROUX	France	Medical Practices	5		Ocrevus (ocrelizumab)
Kliniken Südostbayern AG	Germany	Hospitals and Health Care	210		Ocrevus (ocrelizumab)
Genentech	United States	Biotechnology Research	21k	$26B	Ocrevus (ocrelizumab)
Pharmaceutical Company	Pakistan	Pharmaceutical Manufacturing	10k		Ocrevus (ocrelizumab)

Companies researching Ocrevus (ocrelizumab)

List of companies that research Ocrevus (ocrelizumab)